Get the Free Prostate Cancer Patient Guide now with COVID-19 Appendix.


Go here to learn more or to get a mailed copy.


PCF Catalyzes the Development of Polygenic Test for African American Men at Highest Risk

Studies of cancer in twins have revealed that 57% of all prostate cancer runs in families; one might say that this makes prostate cancer the most “family inherited” form of human cancer.  For the last 20 years, the Prostate Cancer Foundation has been funding the detective work to figure out. Read More


Prostate Cancer’s Sweet Tooth

Cancer loves sugar, and sugar really loves cancer.  Isn’t that sweet?  Actually, no, it’s more like a match made in hell – because sugar (glucose) makes many types of cancer grow faster. Scientists have long known that cancers soak up glucose like a sponge; in fact, German physiologist Otto Warburg,. Read More


Sexual Health After Prostate Cancer: Patients and Partners

When it comes to disrupting your life, prostate cancer cuts quite the swath.   We don’t know exactly how big this trail of disruption is.  We don’t know how bad it is, either. Let’s start with the numbers.  In the U.S. alone, there are more than 3 million men out there. Read More


New Combination Treatment for mCRPC Heads to Phase 3 Trial

At the GU-ASCO meeting held earlier this year, Dr. Neeraj Agarwal of the Huntsman Cancer Center at the University of Utah presented results of a Phase 1b trial of combination therapy with two drugs (cabozantinib + atezolizumab) in metastatic castration resistant prostate cancer (mCRPC). Many treatments for mCRPC exist, but. Read More


Two New Treatments Approved For Advanced Prostate Cancer

This has been a truly historic week, with two new treatment options receiving FDA approval for men with advanced prostate cancer. On Friday, 5/15/20, the FDA approved rucaparib, a new medication to treat some patients with advanced prostate cancer. Then, on Tuesday, 5/19/20, olaparib was approved by the FDA for certain. Read More


HITCH: Years of PCF-Funded Research and Discovery Lead to New PCF-VA Clinical Trial for Veterans With COVID-19

Although the global pandemic-causing coronavirus called COVID-19 has only recently taken over all our lives – killing more Americans in just eight weeks than died in the entire Vietnam War – scientists already know quite a lot about it.  For instance, they know how the virus sneaks into the nose,. Read More


ADT and Your Health During COVID-19

So, there’s a global pandemic.  If you’re on androgen deprivation therapy (hormone therapy, or ADT) for prostate cancer, you may think, “I’ve got enough to worry about.” Well - you may not believe this - but we actually have some good news for you: it looks like one of the. Read More

Radiation Treatment for Prostate Cancer During the COVID-19 Pandemic

A team of researchers led by PCF-funded investigator Dr. Dan Spratt has released a framework for the use of radiation oncology in prostate cancer during COVID-19. The team rapidly reviewed the available literature and issued recommendations for clinicians when considering radiation therapy for prostate cancer patients. The goal is to. Read More


Considering Joining a Prostate Cancer Support Group? Here’s What You Need to Know

When we at PCF and Us TOO first started collaborating on this article, it was business-as-usual: once a man, his partner, or loved one was ready to join a support group, they could call around or look online to find a nearby group, confirm the details, and meet a roomful. Read More


Treatment of Oligometastasis: Update from the ORIOLE Study

To the growing list of strategies for attacking prostate cancer, let us add this approach:  Whack-a-Mole. That’s how Johns Hopkins radiation oncologist Phuoc Tran, M.D., Ph.D., describes it to his patients.  The actual scientific name for this highly sophisticated strategy is stereotactic ablative radiotherapy (SABR, highly focused, intense doses of. Read More